Clinical Trial Update: Neurocognitive Outcomes In Patients Treated With Radiotherapy For Five Or More Brain Metastases [NA]

View source ↗

Summary

The clinical trial evaluating neurocognitive outcomes after radiotherapy for patients with five or more brain metastases has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Metastases

Snippet

Sponsor: University of California, San Francisco | Conditions: Brain Metastases | NA | Status: WITHDRAWN